Wendy R. Galpern
Johnson & Johnson (United States)(US)
Publications by Year
Research Areas
Neurological disorders and treatments, Parkinson's Disease Mechanisms and Treatments, Neuroscience and Neuropharmacology Research, Genetic Neurodegenerative Diseases, Nerve injury and regeneration
Most-Cited Works
- → Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group(2007)528 cited
- → A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease(2014)383 cited
- → Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat.(1994)272 cited
- → Interface between tauopathies and synucleinopathies: A tale of two proteins(2006)264 cited
- → Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: Correlation with PET, microdialysis, and behavioral data(1997)256 cited
- → Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres(1995)225 cited
- → The focal dystonias: Current views and challenges for future research(2013)210 cited
- → Xenotransplantation of Porcine Fetal Ventral Mesencephalon in a Rat Model of Parkinson's Disease: Functional Recovery and Graft Morphology(1996)173 cited
- → Interleukin-1 augments gamma-aminobutyric acidA receptor function in brain.(1991)171 cited
- → Dopamine transporter imaging is associated with long‐term outcomes in Parkinson's disease(2012)133 cited